Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Gail Matters, MS, PhD

Gail Matters, MS, PhD

Associate Professor, Department of Biochemistry and Molecular Biology
Associate Professor, Department of Medicine
Associate Professor, Department of Pharmacology
Scientific Program:Next-Generation Therapies
GLM14@psu.edu

Recent Publications

2024

Abraham, T, Armold, M, McGovern, C, Harms, JF, Darok, MC, Gigliotti, C, Adair, B, Gray, JL, Kelly, DF, Adair, JH & Matters, GL 2024, 'CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery', Biomedicines, vol. 12, no. 5, 1024. https://doi.org/10.3390/biomedicines12051024
Castro, R, Adair, JH, Mastro, AM, Neuberger, T & Matters, GL 2024, 'VCAM-1-targeted nanoparticles to diagnose, monitor and treat atherosclerosis', Nanomedicine, vol. 19, no. 8, pp. 723-735. https://doi.org/10.2217/nnm-2023-0282

2021

Abraham, T, McGovern, CO, Linton, SS, Wilczynski, Z, Adair, JH & Matters, GL 2021, 'Aptamer-targeted calcium phosphosilicate nanoparticles for effective imaging of pancreatic and prostate cancer', International Journal of Nanomedicine, vol. 16, pp. 2297-2309. https://doi.org/10.2147/IJN.S295740
Bussard, KM, Gigliotti, CM, Adair, BM, Snyder, JM, Gigliotti, NT, Loc, WS, Wilczynski, ZR, Liu, ZK, Meisel, K, Zemanek, C, Mastro, AM, Shupp, AB, McGovern, C, Matters, GL & Adair, JH 2021, 'Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 34, 102383. https://doi.org/10.1016/j.nano.2021.102383